Luciferase Reporter Cell Line - U251MG

U251MG cells are a human glioblastoma multiforme (GBM)-derived cell line widely used as an in vitro model for studying aggressive brain tumor biology and glioma progression. These cells are characterized by high proliferative capacity, invasive behavior, and genetic alterations commonly associated with high-grade gliomas, including dysregulation of pathways involved in cell survival, migration, angiogenesis, and resistance to therapy. U251MG cells exhibit mesenchymal-like features and are frequently used to model the highly heterogeneous and treatment-resistant nature of glioblastoma. The Luciferase Reporter Cell Line – U251MG is generated through stable integration of a luciferase reporter construct driven by pathway-responsive elements or specific transcription factor–binding promoters into the parental U251MG background, enabling real-time, quantitative monitoring of transcriptional and signaling activities while maintaining the intrinsic biological characteristics of the original glioma cell line.

The Luciferase Reporter Cell Line – U251MG is widely applied in neuro-oncology research, drug screening, and signaling pathway analysis in glioblastoma. It is particularly useful for studying key oncogenic and tumor microenvironment–related pathways, including NF-κB, STAT3, PI3K/AKT/mTOR, MAPK/ERK, and hypoxia-inducible factor (HIF) signaling, all of which contribute to tumor growth, immune evasion, and therapeutic resistance. The luciferase reporter system provides a sensitive and quantitative readout for evaluating pathway modulation in response to pharmacological compounds, biologics, or genetic interventions. This model is commonly used in high-throughput screening of anti-glioma agents, as well as in mechanistic studies of tumor invasion, stemness, and resistance to radiotherapy or chemotherapy. Its robustness, reproducibility, and strong signal sensitivity make it a valuable tool for both fundamental research and preclinical development of targeted therapies for glioblastoma.